𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Profile of families with parkinsonism-predominant spinocerebellar ataxia type 2 (SCA2)

✍ Scribed by Sarah Furtado; Haydeh Payami; Paul J. Lockhart; Melissa Hanson; John G. Nutt; Andrew A. Singleton; Amanda Singleton; Jamel Bower; Ryan J. Utti; Thomas D. Bird; Raul de la Fuente-Fernandez; Yoshio Tsuboi; Mary L. Klimek; Oksana Suchowersky; John Hardy; Donald B. Calne; Zbigniew K. Wszolek; Matthew Farrer; Katrina Gwinn-Hardy; A. Jon Stoessl

Publisher
John Wiley and Sons
Year
2004
Tongue
English
Weight
79 KB
Volume
19
Category
Article
ISSN
0885-3185

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Spinocerebellar ataxia type 2 (SCA2) has been recognized recently as an uncommon cause of parkinsonism, an alternate presentation to the typical cerebellar disorder. This research review summarizes the existing literature on parkinsonism‐predominant presentation SCA2 and presents new clinical cases of patients with this condition. Various phenotypes are noted in this subtype of SCA2, including parkinsonism indistinguishable from idiopathic Parkinson's disease (PD), parkinsonism plus ataxia, motor neuron disease, and postural tremor. In several kindreds with multiple affected family members, the SCA2 expansion segregated with disease; in addition, several single cases of parkinsonism with and without a family history are also described. The number of repeats in symptomatic patients ranged from 33 to 43. Interruption of the CAG repeat with CAA, CGG, or CCG was found in some individuals, possibly stabilizing the repeat structure and accounting for the relative stability of the repeat size across generations in some families; allele length is not necessarily indicative of trinucleotide repeat architecture. Positron emission tomography scanning in one family showed reduced fluorodopa uptake and normal to increased raclopride binding with a rostrocaudal gradient similar to that found in idiopathic PD. This review emphasizes the importance of testing for SCA2 in patients with parkinsonism and a family history of neurodegenerative disorders. Testing for SCA2 is also important in studies of inherited parkinsonism. Β© 2004 Movement Disorder Society

πŸ“œ SIMILAR VOLUMES

Dopa-responsive parkinsonism phenotype o
Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2
✍ Chin-Song Lu; Yah-Huei Wu Chou; Tzu-Chen Yen; Chon-Haw Tsai; Rou-Shayn Chen; Hsi πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 208 KB

## Abstract We report on 2 brothers, Patients 1 and 2, who presented with a similar clinical syndrome consisting of resting tumor, bradykinesia, rigidity, and dysarthria at the ages of 40 and 43 years, respectively. An excellent response to levodopa therapy was observed throughout the disease cours

Spinocerebellar ataxia type 2 (SCA 2) in
Spinocerebellar ataxia type 2 (SCA 2) in an infant with extreme CAG repeat expansion
✍ Babovic-Vuksanovic, Dusica; Snow, Karen; Patterson, Marc C.; Michels, Virginia V πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 16 KB πŸ‘ 2 views

Autosomal dominant cerebellar ataxias are a heterogeneous group of neurodegenerative disorders that generally present in adulthood. Spinocerebellar ataxia type 2 typically presents with progressive cerebellar symptoms, slow ocular saccades, and peripheral neuropathy. The onset of symptoms is usually

Spinocerebellar ataxia type 2 (SCA2) pre
Spinocerebellar ataxia type 2 (SCA2) presenting with ophthalmoplegia and developmental delay in infancy
✍ Moretti, Paolo ;Blazo, Maria ;Garcia, Leonardo ;Armstrong, Dawna ;Lewis, Richard πŸ“‚ Article πŸ“… 2004 πŸ› John Wiley and Sons 🌐 English βš– 136 KB

An 11-year-old boy was evaluated for progressive ataxia, cognitive deterioration, and ophthalmoplegia. The child initially presented with abnormal eye movements at the age of 2 months and was noted to have developmental delay at 6 months. At the age of 7 years, he developed ataxia and cognitive impa